T2386 |
Pirfenidone
|
53179-13-8
|
99.93%
|
|
Pirfenidone (AMR69) is an inhibitor for TGF-β production and TGF-β stimulated collagen production. Pirfenidone inhibits fibroblast, epidermal, platelet-derived, ...
|
T4300 |
AZD2098
|
566203-88-1
|
99.92%
|
|
AZD2098 is a potent CC-chemokine receptor 4 (CCR4) inhibitor used for asthma research.
|
T16111 |
ML604086
|
850330-18-6
|
99.91%
|
|
ML604086 suppresses CCL1 mediated chemotaxis and enhances intracellular Ca2 concentrations. ML604086 is a selective inhibitor of CCR8. It also inhibiting CCL1 bi...
|
T3188 |
RE-640
|
140926-75-6
|
99.91%
|
|
NSC-5844 (RE-640) (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.
|
T60145 |
CCR6 antagonist 1
|
588674-64-0
|
99.89%
|
|
CCR6 antagonist 1, a chemical compound acting as a CCR6 antagonist, effectively inhibits the CCL20/CCR6 axis. Its utility lies in research focused on autoimmune-...
|
T2375 |
BX471
|
217645-70-0
|
99.85%
|
|
BX471 (BX 471) is a potent, selective non-peptide CCR1 antagonist.
|
T10156 |
CCR3 antagonist 1
|
879399-82-3
|
99.85%
|
|
CCR3 antagonist 1 is a potent CCR3 antagonist, used for the research of inflammatory and immunologic diseases.
|
T11481 |
GSK2239633A
|
1240516-71-5
|
99.78%
|
|
GSK2239633A is an allosteric antagonist of CC-chemokine receptor 4 (CCR4) with a pIC50 of 7.96 for the binding of [125I]-TARC to human CCR4.
|
T3327 |
Artemotil
|
75887-54-6
|
99.76%
|
|
Artemotil (SM-227) is a new, fast-acting antimalarial drug.
|
T30258 |
AZD-4818
|
1003566-93-5
|
99.75%
|
|
AZD-4818 (CCR1 antagonist) is a chemokine CCR1 antagonist for the treatment of chronic obstructive pulmonary disease.
|
T15641 |
K777
|
233277-99-1
|
99.71%
|
|
K777 is a potent, orally active and irreversible inhibitor of cysteine protease. K777 is a potent CYP3A4 inhibitor (IC50= 60 nM). K777 is also a selective CCR4 a...
|
T12773 |
RS102895 hydrochloride
|
1173022-16-6
|
99.7%
|
|
RS102895 hydrochloride is a potent antagonist of CCR2(IC50 of 360 nM).
|
T4584 |
BMS-813160
|
1286279-29-5
|
99.66%
|
|
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular.
|
T14900 |
CCR2-RA-[R]
|
512177-83-2
|
99.65%
|
|
CCR2-RA-[R] is a C-C chemokine receptor type 2 (CCR2) allosteric antagonist (IC50: 103 nM).
|
TN1273 |
7,4'-Dihydroxyflavone
|
2196-14-7
|
99.6%
|
|
7,4'-Dihydroxyflavone (4',7-Dihydroxyflavone) can induce transcription of nodulation (nod) genes in Rhizobium meliloti. It has inhibitory activities against COX-...
|
T7499 |
TAK-779
|
229005-80-5
|
99.58%
|
|
TAK-779 (Takeda 779) is an antagonist of chemokine receptor 5 (CCR5), CCR2b, and CXC chemokine receptor 3 (CXCR3).
|
TQ0283 |
RS102895
|
300815-41-2
|
99.54%
|
|
RS102895 is a potent CCR2 antagonist (IC50: 360 nM) and shows no effect on CCR1.
|
T3430 |
PF-4136309
|
1341224-83-6
|
99.52%
|
|
PF-4136309 (INCB8761) is a specific, effective, and orally bioavailable CCR2 antagonist.
|
T17225 |
Vercirnon
|
698394-73-9
|
99.15%
|
|
Vercirnon (Traficet-EN) is a selective and potent antagonist of CCR9 (IC50: 10 nM). It is also used in the research of inflammatory bowel diseases.
|
T23321 |
SB 328437
|
247580-43-4
|
99.11%
|
|
SB 328437 ((S)-methyl 2-(1-naphthamido)-3-(4-nitrophenyl)propanoate) is an effective and selective antagonist of CCR3 (IC50 = 4.5 nM).
|